NCT00652808View on ClinicalTrials.gov

Double-Blind, Double Dummy, Randomized Comparison Study to Evaluate the Efficacy and Safety of Valdecoxib 10 mg Once Daily and Naproxen 500 mg Twice Daily in Treating the Signs and Symptoms of Osteoarthritis of the Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

September 30, 2004

Conditions
OsteoarthritisKnee
Interventions
DRUG

valdecoxib

valdecoxib 10 mg tablet by mouth once daily for 6 weeks

DRUG

naproxen

naproxen 500 mg capsule by mouth twice daily for 6 weeks

Trial Locations (8)

431-070

Pfizer Investigational Site, Anyang

501-757

Pfizer Investigational Site, Gwangju

405-760

Pfizer Investigational Site, Incheon

602-739

Pfizer Investigational Site, Pusan

110-744

Pfizer Investigational Site, Seoul

137-701

Pfizer Investigational Site, Seoul

138-736

Pfizer Investigational Site, Seoul

152-703

Pfizer Investigational Site, Seoul

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY